참고문헌
- Bernier AJ, Zhang J, Lillehoj E, et al (2011). Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion. Mol Cancer, 10, 93. https://doi.org/10.1186/1476-4598-10-93
- Besmer DM, Curry JM, Roy LD, et al (2011). Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis. Cancer Res, 71, 4432-42. https://doi.org/10.1158/0008-5472.CAN-10-4439
- Cascio S, Zhang L, Finn OJ (2011). MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-kappaB p65 and binding to cytokine promoters. J Biol Chem, 286, 42248-56. https://doi.org/10.1074/jbc.M111.297630
- Colditz GA, Bohlke K, Berkey CS (2014). Breast cancer risk accumulation starts early: prevention must also. Breast Cancer Res Treat, 145, 567-79 https://doi.org/10.1007/s10549-014-2993-8
- Fardmanesh H, Shekari M, Movafagh A, et al (2016). Upregulation of the double-stranded RNA binding protein DGCR8 in invasive ductal breast carcinoma. Gene, 58, 146-51.
- Fontenot JD, Mariappan SV, Catasti P, et al (1995). Structure of a tumor associated antigen containing a tandemly repeated immunodominant epitope. J Biomol Struct Dyn, 13, 245-60. https://doi.org/10.1080/07391102.1995.10508837
- Heidari MH, Porghasem M, Mirzaei N, et al (2014). The effect of high level natural ionizing radiation on expression of PSA, CA19-9 and CEA tumor markers in blood serum of inhabitants of Ramsar, Iran. J Environ Radioact, 128, 64-7. https://doi.org/10.1016/j.jenvrad.2013.11.001
- Hollingsworth MA, Swanson BJ (2004). Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer, 4, 45-60. https://doi.org/10.1038/nrc1251
- Kamata M, Denda-Nagai K, Kubota N, et al (2002). Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases. Clin Exp Metastasis, 19, 689-96. https://doi.org/10.1023/A:1021332932531
- Kimura T, Tanaka S, Haruma K, et al (2000). Clinical significance of MUC1 and E-cadherin expression, cellular proliferation, and angiogenesis at the deepest invasive portion of colorectal cancer. Int J Oncol,16, 55-64.
- Ma Y, Ye F, Xie X, et al (2010). Significance of PTPRZ1 and CIN85 expression in cervical carcinoma. Arch Gynecol Obstet, 284, 699-704.
- Movafagh A, Hajifathali A, Isfahani F, et al (2012). Geographic heterogeneity of cytogenetic characteristics of acute myeloid leukemia in the early detection. Iran J Cancer Prev, 2, 85-9.
- Movafagh A, Mirfakhraei R, Mousavi-Jarrahi A (2011). Frequent incidence of double minute chromosomes in cancers, with special up-to-date reference to leukemia. Asian Pac J Cancer Prev, 12, 3453-6.
- Movafagh A, Hajifathali A, Zamani M (2011). Secondary chromosomal abnormalities of de novo acute myeloid leukemia-a first report from the Middle East. Asian Pac J Cancer Prev, 12, 2991-4.
- Nishidate T, Katagiri T, Lin ML, et al (2004). Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identificationof genes associated with progression and metastasis. Int J Oncol, 25, 797-819.
- Ouellette RJ, Richard D, Maicas E (2004). RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes. Am J Clin Pathol, 121, 637-43. https://doi.org/10.1309/MMACTXT55L8QTKC1
- Pegoraro S, Ros G, Piazza S, et al (2013). HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stem ness. Oncotarget, 4, 1293-308. https://doi.org/10.18632/oncotarget.1136
- Roy LD, Sahraei M, Subramani DB, et al (2010). MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene, 30,1449-59.
- Saintigny P, Coulon S, Kambouchner M, et al (2005). Real-time RT-PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinoma. Int J Cancer, 115, 777-82. https://doi.org/10.1002/ijc.20942
- Schroeder JA, Adriance MC, Thompson MC, et al (2003). MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion. Oncogene, 22, 1324-32. https://doi.org/10.1038/sj.onc.1206291
- Seifi-Alan M, Shamsi R, Ghafouri-Fard S, et al (2014). Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines. Asian Pac J Cancer Prev, 14, 6625-9.
- Shargh SA, Sakizli M, Khalaj V, et al. (2014) Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and its relation with progression and prognosis of tumor. Med Oncol, 31, 250. https://doi.org/10.1007/s12032-014-0250-y
- Suzuki H, Shoda J, Kawamoto T, et al (2004). Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma. Clin Exp Metastasis, 21, 321-9. https://doi.org/10.1023/B:CLIN.0000046133.35133.cc
- Taylor-Papadimitriou J, Burchell JM, Plunkett T, et al (2002). MUC1 and the immunobiology of cancer. J Mammary Gland Biol Neoplasia, 7, 209-21. https://doi.org/10.1023/A:1020360121451
- Tinder TL, Subramani DB, Basu GD, et al (2008). MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma. J Immunol, 181, 3116-25. https://doi.org/10.4049/jimmunol.181.5.3116
- Wakasaki T, Masuda M, Niiro H, et al (2010). A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway. Neoplasia, 12, 789-96. https://doi.org/10.1593/neo.10396
- Wang X, Zachary S, Vierkant RA, et al (2010). Association of genetic variation in mitotic kinases with breast cancer risk. Breast Cancer Res Treat, 119, 453-62. https://doi.org/10.1007/s10549-009-0404-3
- Wei X, Xu H, Kufe D (2006). MUC1 oncoprotein stabilizes and activates estrogen receptor alpha. Mol Cell, 20, 295-305.
피인용 문헌
- The application of aptamer 5TR1 in triple negative breast cancer target therapy vol.119, pp.1, 2018, https://doi.org/10.1002/jcb.26254